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In vitro exposure of isolated rat kidney mitochondria to cyclosporin A, a new immunosuppressive ag nt 
with serious nephrotoxic side-effects, leads to alterations ofboth succinate- and glutamate plus malate-sup- 
ported respiration i a dose-related manner. ADP- and 2,4-dinitrophenol-stimulated respiration, respiratory 
control indices, and ADP/O ratios are decreased. The mitochondrial terations are discussed as possible 
pathogenetic reasons of cyclosporin A nephrotoxicity. 
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1. INTRODUCTION 
Cyc A has proved to be a powerful immunosup- 
pressive agent in renal, liver, heart, and pancreatic 
transplantation (for a recent review, see [I]). 
However, nephrotoxicity has been described as one 
of the most serious side-effects of this novel phar- 
macological product [l-3]. Ultrastructural studies 
have shown that the proximal tubular cells, but not 
the glomerulus and other parts of the nephron are 
affected [4,5]. Hitherto, the molecular processes 
mediating this nephrotoxic effect of Cyc A were 
unknown. One possible mechanism may be the in- 
jury of energy metabolism in the affected cells. 
The present study was designed to evaluate the 
influence of Cyc A on respiration in rat renal cor- 
tical mitochondria. The results provide evidence 
that Cyc A nephrotoxicity may be caused by an 
alteration of mitochondrial respiration. 
2. MATERIALS AND METHODS 
Male Wistar rats (VEB Versuchstierproduktion 
Schonwalde, GDR) weighing 250-300 g were kill- 
Abbreviations: CYC A, cyclosporin A; DNP, 
2,4_dinitrophenol; RCI, respiratory control index 
ed by a blow to the head and both kidneys were 
rapidly excised and immediately immersed in an 
ice-cold preparation medium. The medium con- 
tained 210 mM mannitol, 70 mM sucrose, and 
0.5 mM EDTA buffered at pH 7.4 with traces of 
Tris. The kidneys were split in half longitudinally 
and the medulla was removed. The remaining cor- 
tical tissue was placed in the preparation medium, 
minced, rinsed and homogenized in a Potter- 
Elvehjem glass homogenizer with a Teflon pestle. 
The homogenate was centrifuged for 10 min at 
800 x g in a refrigerated centrifuge (Model K 24, 
VEB Zentrifugenbau Leipzig, GDR). The resulting 
supernatant was centrifuged for 5 min at 12000 x 
g. The pellet was then resuspended in preparation 
medium to a concentration of about 10 mg 
mitochondrial protein per ml and stored on ice. 
Throughout the isolation procedure the tissue and 
all solutions were kept at 0-4’C. 
Respiratory measurements were carried out with 
a Clark oxygen electrode (VEB Metra Radebeul, 
GDR) at 25°C in a closed oxygraph cell. The 
medium contained 210 mM sucrose, 10 mM KCI, 
10 mM KHzPOd, 0.5 mM EDTA, 60 mM Tris- 
HCl (pH 7.4), either 10 mM succinate or a mixture 
of 10 mM glutamate and 10 mM malate, and an 
aliquot of mitochondrial suspension (about 1 mg 
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protein) in a final volume between 2.20-2.26 ml. 
30 ~1 of different Cyc A dilutions in 154 mM NaCl 
were added. The following parameters of 
mitochondrial respiration were studied: state 3 
respiration, the rate of 02 consumption measured 
in the presence of 100 PM ADP added 1 min after 
adding Cyc A; state 4 respiration, the slower rate 
measured following the depletion of ADP; the 
RCI, the ratio of state 3 to state 4; the ADP/O 
ratio, the ratio of added ADP to the oxygen con- 
sumed in state 3; and the DNP-stimulated respira- 
tion, oxygen consumption measured in the 
presence of 50 nM DNP. All respiratory rates were 
calculated as nmol 02 utilizedimin per mg 
mitochondrial protein. The calculations were 
related to an 02 solubility of 240 mM in the 
medium at 25°C. 
Protein determinations were made by a Biuret 
method [6] with crystallized human serum albumin 
as standard. ADP was determined with an ADP- 
test combination (Boehringer, Mannheim; FRG). 
Statistical analyses were performed with the Stu- 
dent’s t-test. 
ADP and succinate were from Boehringer, 
glutamate from Reanal (Budapest) and Cyc A 
from Sandoz, Basle. Other chemicals and 
biochemicals on analytical grade were obtained 
from Merck, Darmstadt and VEB Laborchemie 
Apolda (GDR). 
3. RESULTS 
Both succinate- and glutamate plus malate- 
supported respiration of renal cortical mitochon- 
Table 1 
Glutamate plus malate supported respiration of rat kidney mitochondria depending on cyclosporin A concentration in 
the incubation medium 
Cyc A 
Ocg/ml) 
Respiratory rates (nmol Oz/mg protein per min) 
State 4 State 3 DNP 
RCI ADP/O 
0 8.7 t 0.6 69.0 L 9.0 72.4 -+ 11.3 7.99 * 1.4 2.61 2 0.1 
1 8.9 + 0.9 65.8 + 8.1 62.1 + 9.4 7.45 * 1.5 2.64 + 0.1 
5 10.2 + 1.9 54.8 f 8.4 56.6 f 8.5 5.48 +_ 1.4 2.49 +_ 0.1 
10 11.0 + 1.8b 43.3 + 5.2b 47.1 + 5.5b 3.98 * 0.7 2.37 + 0.3 
50 17.3 * 2.1C 24.1 + 1.3’ 29.5 2 7.9b 1.41 * 0.2 2.06 + 0.2b 
75 19.7 + 1.6’ 21.8 ? 1.9’ 23.8 + 2.1’ 1.14 * 0.0’ 2.42 + 0.4 
Data are given as arithmetic means rt 1 SD of 5 separate preparations. Differences to the controls: a p < 0.05; b p < 
0.01; ’ p < 0.001. Further details, see section 2 
Table 2 
Succinate supported respiration of rat kidney mitochondria depending on cyclosporin A concentration in the incubation 
medium 
Cyc A 
Wml) 
0 
1 
5 
10 
50 
75 
Respiratory rates (nmol 02/mg protein per min) 
State 4 State 3 
16.0 + 0.8 112 It_ 13.3 
16.2 + 0.9 113 jI 14.1 
16.7 f 1.2 100 + 11.4 
16.7 + 0.4 90.6 +_ 9.8” 
20.3 t 1.3’ 60.2 * 6.5’ 
21.3 it_ 1.1’ 54.1 -t 8.9’ 
DNP 
109 f 15.5 
110 + 15.7 
101 ? 12.9 
97.7 + 13.9 
70.1 + 9.8b 
62.7 +- 12.1b 
RCI ADP/O 
6.96 k 0.6 1.93 & 0.2 
6.92 + 0.8 1.94 + 0.1 
5.98 f 0.3” 1.81 +_ 0.1 
5.43 2 0.6” 1.70 f 0.2 
2.99 _t 0.5’ 1.69 _t 0.1” 
2.56 ? 0.5’ 1.68 ? 0.1” 
For further details, see table 1 
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dria appear affected by Cyc A in a dose-rdated rats led to a concentration of about 8Oplg per g 
fashion (tables t,2). State 3 and DNP-stimulated kidney tissue. In general, immune suppression in 
respiration are inhibited and state 4 respiration is rats has been achieved with dose ranges of Gyc A 
increased. Therefore, the decline of RCI seems to between 5 and 50 mg/kg per day [l]. Taking into 
be the most sensitive parameter for detecting the account the pharmacokinetic behaviour of Cyc A 
mitochondrial dysfunction. The GDP/O ratio, [9] we suggest. hat Cyc A levels in kidneys occur 
however, is only slightly affected. The influence of which could provoke the effects demonstrated here 
Cyc A on mitochondria is more evident for the by in vitro experiments. In fact, structural altera- 
glutamate plus malate- than succinate-supported tions of renal mitochondria have been reported in 
respiration. patients receiving Cyc A [ 101. 
4. DISCUSSION 
Our results indicate that Cyc A interferes, like 
other nephrotoxic drugs, especially aminogly- 
coside and cephalosporin antibiotics [7], with 
the mitochondrial energy generation. The in vitro 
exposure of renal mitochondria to Cyc A has 
shown a deterioration of mitochondrial respiration 
in a manner similar to that observed with gen- 
tamicin: the ADP- and DNP-stimulated respira- 
tion is decreased and the resting state (state 4) 
respiration is increased. Cyc A alters the 
mitochondrial properties already at concentrations 
between 40 and 80 nM. Threshold concentrations 
of gentamicin for the same effects were at higher 
concentrations, between 1 and 2 mM [8]. These ef- 
fects of Cyc A suggest hat this drug acts both as 
inhibitor of mitochondrial electron transport 
system and uncoupler. Since state 3 of glutamate 
plus malate-supported respiration is influenced at 
a lower concentration than succinate-supported 
respiration, it seems very likely that Cyc A inhibits 
mitochondrial electron transport system at several 
sites. 
In summary, the study clearly demonstrates that 
renal mitochondria exposed to Cyc A in vitro ex- 
hibit alterations in respiratory parameters. This 
mitochondrial injury may be an important 
pathogenetic mechanism of Cyc A nephrotoxicity. 
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